Spero Therapeutics, Inc. (SPRO)

2.22 -0.08 (-3.48%) USD  |  NASDAQ  |  Feb 23, 13:37
More

Spero Therapeutics Annual EBITDA Margin Estimates

Annual EBITDA Margin Estimates Chart

View Annual EBITDA Margin Estimates for SPRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EBITDA Margin Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EBITDA Margin Estimates Range, Past 5 Years

View Annual EBITDA Margin Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EBITDA Margin Estimates Benchmarks

View Annual EBITDA Margin Estimates Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Cassava Sciences, Inc. --
Alpha Teknova, Inc. Upgrade
Pyxis Oncology, Inc. --